Philippe G Steg Selected Research

Philippe G Steg Research Topics

Disease

13	Myocardial Infarction 01/2023 - 11/2005
9	Heart Failure 11/2021 - 07/2002
7	ST Elevation Myocardial Infarction 01/2023 - 02/2017
6	Acute Coronary Syndrome 01/2021 - 01/2007
4	Hemorrhage 12/2022 - 01/2007
4	Stroke (Strokes) 12/2020 - 04/2006
4	Cardiovascular Diseases (Cardiovascular Disease) 12/2020 - 06/2014
4	Thrombosis (Thrombus) 09/2019 - 12/2013
3	Obesity 01/2021 - 05/2006
3	Dyspnea (Shortness of Breath) 10/2004 - 07/2002
2	Atrial Fibrillation 01/2023 - 10/2019
2	Coronary Artery Disease (Coronary Atherosclerosis) 12/2013 - 04/2006
1	Atherosclerosis 01/2023
1	Non-ST Elevated Myocardial Infarction 01/2021
1	Hypertension (High Blood Pressure) 01/2021
1	Peripheral Vascular Diseases (Peripheral Vascular Disease) 12/2020
1	Embolism (Embolus) 10/2019
1	Ischemia 09/2019
1	Death (Near-Death Experience) 01/2018
1	Coronary Disease (Coronary Heart Disease) 01/2007
1	Overweight 05/2006
1	Left Ventricular Dysfunction 04/2006
1	Heart Arrest (Cardiac Arrest) 04/2006
1	Stable Angina 11/2005
1	Lung Diseases (Lung Disease) 03/2003

Drug/Important Bio-Agent (IBA)

7	Brain Natriuretic Peptide (Natrecor)FDA Link 05/2006 - 07/2002
4	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 11/2021 - 04/2006
3	Biomarkers (Surrogate Marker)IBA 11/2020 - 09/2017
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2021 - 11/2020
2	Clopidogrel (Plavix)FDA Link 01/2021 - 09/2019
2	TicagrelorIBA 01/2021 - 11/2020
2	TroponinIBA 11/2020 - 09/2017
2	CholesterolIBA 11/2020 - 10/2016
2	Heparin (Liquaemin)FDA LinkGeneric 08/2017 - 01/2007
1	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 12/2022
1	sacubitril and valsartan sodium hydrate drug combinationIBA 11/2021
1	Angiotensin Receptors (Angiotensin II Receptor)IBA 11/2021
1	Neprilysin (Neutral Endopeptidase)IBA 11/2021
1	sacubitrilIBA 11/2021
1	Valsartan (Vals)FDA Link 11/2021
1	Ramipril (Altace)FDA LinkGeneric 11/2021
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2021
1	Prasugrel Hydrochloride FDA Link 01/2021
1	LDL CholesterolIBA 01/2021
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2021
1	Angiotensin Receptor AntagonistsIBA 01/2021
1	pro-brain natriuretic peptide (1-76)IBA 12/2019
1	Growth Differentiation Factor 15IBA 12/2019
1	Interleukin-18 (Interleukin 18)IBA 12/2019
1	Cystatin CIBA 12/2019
1	Vitamin K FDA Link 10/2019
1	AnticoagulantsIBA 10/2019
1	apixabanIBA 10/2019
1	RivaroxabanIBA 10/2019
1	Dabigatran FDA Link 10/2019
1	Streptokinase FDA Link 09/2019
1	cangrelorIBA 09/2019
1	omega-Chloroacetophenone (Mace)IBA 01/2018
1	Adenosine Diphosphate (ADP)IBA 12/2017
1	bivalirudin (Angiomax)FDA Link 08/2017
1	Glycoproteins (Glycoprotein)IBA 08/2017
1	Enoxaparin (Lovenox)FDA LinkGeneric 08/2017
1	HDL LipoproteinsIBA 10/2016
1	Apolipoprotein A-I (Apolipoprotein A1)IBA 10/2016
1	CSL112IBA 10/2016
1	MetalsIBA 12/2013
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 01/2007

Therapy/Procedure

6	Percutaneous Coronary Intervention 01/2023 - 08/2017
4	Stents 09/2019 - 12/2013
3	Therapeutics 11/2021 - 01/2007
2	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 12/2020 - 09/2017
1	Secondary Prevention 01/2023
1	Conservative Treatment 09/2017
1	Drug Therapy (Chemotherapy) 10/2016
1	Length of Stay 06/2014
1	Drug-Eluting Stents 12/2013
1	Resuscitation 04/2006
1	Myocardial Revascularization 04/2006